These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Plasma concentration of aldosterone, 18-hydroxy-deoxycorticosterone and cortisol in adrenal veins of patients with low-renin hypertension. Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E Horm Metab Res; 1977 Sep; 9(5):403-9. PubMed ID: 200537 [No Abstract] [Full Text] [Related]
6. [Importance of the simultaneous estimation of aldosterone, 18-hydroxy-11-deoxycorticosterone and cortisol in the adrenal veins in arterial hypertension with suppressed renin (author's transl)]. Horký K; Gregorová I; Tomsová Z; Vancura J; Silinková-Málková E Sb Lek; 1977 Jan; 79(1):1-10. PubMed ID: 841259 [No Abstract] [Full Text] [Related]
7. 18-hydroxy-11-deoxycorticosterone response to ACTH, insulin and furosemide administration in essential hypertensive patients. Tosti-Croce C; Giaquinto G; Graziosi S; Odoardi A; Sparano F; Sciarra F Horm Res; 1981; 15(1):28-36. PubMed ID: 6277757 [TBL] [Abstract][Full Text] [Related]
8. Adrenocorticosteroids in experimental and human hypertension. Melby SC; Dale SL J Endocrinol; 1979 May; 81(2):93P-106P. PubMed ID: 458347 [No Abstract] [Full Text] [Related]
9. [Role of the anterior pituitary gland in the regulation of 18-hydroxydesoxycorticosterone by the adrenal cortex]. Bobkova AS; Golikov PP Probl Endokrinol (Mosk); 1980; 26(4):51-5. PubMed ID: 6251446 [TBL] [Abstract][Full Text] [Related]
10. Effect of aminoglutethimide on blood pressure and steroid secretion in patients with low renin essential hypertension. Taylor AA; Mitchell JR; Bartter FC; Snodgrass WR; McMurtry RJ; Gill JR; Franklin RB J Clin Invest; 1978 Jul; 62(1):162-8. PubMed ID: 149141 [TBL] [Abstract][Full Text] [Related]
11. New mineralocorticoids and adrenocorticosteroids in hypertension. Melby JC; Dale SL Am J Cardiol; 1976 Nov; 38(6):805-13. PubMed ID: 136892 [TBL] [Abstract][Full Text] [Related]
16. [Physiological regulation and clinical significance of 18-hydroxy-11-deoxycorticosterone]. Li G; Kuang AK; Ding T Zhonghua Nei Ke Za Zhi; 1985 Feb; 24(2):94-7, 126. PubMed ID: 2985345 [No Abstract] [Full Text] [Related]
17. Proceedings: Effects of 18-hydroxydeoxycorticosterone on stress-induced release of corticotrophin. Tiptaft E; Jones MT J Endocrinol; 1976 Jun; 69(3):33P-34P. PubMed ID: 181512 [No Abstract] [Full Text] [Related]
18. Radioimmunoassay of free urinary 18-hydroxydeoxycorticosterone (18-OH-DOC) in patients with essential hypertension. Hornung J; Gless KH; Abdelhamid S; Vielhauer W; Vecsei P Clin Chim Acta; 1978 Jul; 87(2):181-7. PubMed ID: 657546 [TBL] [Abstract][Full Text] [Related]
19. Mineralocorticoid properties of potential metabolites of 18-hydroxydeoxycorticosterone and 18-hydroxyprogesterone. Weet JF; Lenz GR J Med Chem; 1985 Feb; 28(2):233-9. PubMed ID: 3155800 [TBL] [Abstract][Full Text] [Related]
20. The regulation of plasma 18-hydroxy 11-deoxycorticosterone in man. Williams GH; Braley LM; Underwood RH J Clin Invest; 1976 Jul; 58(1):221-9. PubMed ID: 180059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]